NEW YORK (GenomeWeb News) — Genetic Technologies today said it has licensed its non-coding DNA patents to Viennese diagnostics company GenoSense.
Under the nine-year deal, GenoSense bought worldwide licensing rights to use Genetic Technologies’ technology in its anti-aging diagnostics and preventive testing services.
In a statement, the companies also said the “have identified a number of mutually beneficial global business opportunities that will be explored over the coming months.” The statement didn’t elaborate.
Financial terms of the agreement were not released.